NYD do you actually have anything NEW to post here? You

New Post Public Reply Private Reply Replies (3) Message Board
Zolis_onkel NYD #34662
603
NYD do you actually have anything NEW to post here?
You sound like a daamaged, old fashioned vinyl record that is playing the same one turn again and again.

Let me just reply to some of the most negative generalisations from your last post:

1) 2+ years plus of continuous investigation.
a) This is not true. It has first been a deep dive into the 2019 10-K that lasted 10 months. According to Joe's statements this was related to the "soon to happen" IPO of NGIO, where the SEC wanted to have a "closer look" into the company that applied to have one of its subsidiaries listed on NASDAQ. This is somewhat understandable and reasonable, while the time it took (10+ months) surely NOT. GNBT came out of this investigation fair and square, and after that they actually did communicate to us and e.g. held the May CC last year, where everything sounded quite good and rosy.
b) Then sometime after the May CC another (assumed) investigation started. Which means there was time inbetween where they communicated with us, and then some entity (not necessarily the SEC) started another investigation. For me the most likely candidate or reason foer that investigation would be that entire NGUX dilemma, which has very little to do with Joe's "terrible leadership" except for the fact that the crooks, who set this up, were obviously pissed off, because the IPO took significantly longer than expected, and they were stuck with their dividend shares (welcome to the club; ... in fact I still have never seen them in my account in the first place) and were not able to turn them into cash quickly enough. Still, if you are dealing with such "bad actors" there is most of the time very little the current management team is able to do about it.
For me it is very easy to always just blame it on the usual suspect, but here (in case my assumption (SEC investigation regarding the NGUX shananigans) is correct) it might as well be not really Joe's fault.
2) You keep reiterating that Joe and team are voluntarily not communicating with us.
a) In fact this is not true, because Todd seems to be willing and able to quickly reply to emails with standard statements, and with demonstrating that in fact "the lights are still on" within the company, and telling us that they are not going to give up, but dealing with "some serious issues" that they obviously are confronted with. They are also aware that we shareholders are very much on the edge and desparate to receive an update from the company. He already promised that they "will update shareholders as soon as that will be possible". This implies time and time again that it currently is NOT possible, so someone or something is keeping them from doing so. That means it has nothing to do with they not being willing to do so.
b) from exeperience of the years prior to the 10-K investigation we all know that they have been very communicative with us, so I do not see any reason why they would voluntarily change their ways so significantly if they are not forced to do so.

3) Not released Ks and Qs. This might as well be related to the (assumed) ongoing investigation. As long as the investigation is not completed e.g. the share structure of GNBT and NGIO might still remain unclear regarding the NGUX issue, or questions regarding, who would receive or not receive the NGIO dividend. And as long as that remains unclear, the SEC might have asked them to not issue Ks and Qs with potentially false such statements included.

4) BOD members leaving and head quarters abandoned (or they being evicted from them).
I have no good explanation for that neither, but all I hear from you is "doom and gloom", while you do not know any better neither, and there still might be a good reason for it that none of us know. As long as I do not know any better I tend to believe in a positive outcome, and I still think that there are enough good reasons to still believe in such a positive outcome. One being the fact that Joe currently is in Dubai on a business trip smiling into cameras and looking reasonably upbeat, especially when we all consider the terrible situation that we all assume he is in as the CEO of the two companies.

So I can just ask everyone on here again not to plan a funeral for a company and its sub, as long as noone knows what is really going on and whether the companies are already dead or at least close to.

Thanks a lot and have a great weekend everyone.
2

Generex Biotechnology Corp. (GNBTQ) Stock Research Links

GNBTQ Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Uber Data Breach: Class Action Investigation Begins

Updated Category News Views 202

When Tech Meets Trouble: Uber's Data Breach Picture this: the hum of Uber rides weaving through your city, drivers none the wiser that personal info has been pried from the vaults thanks to their tech partner, Fireworks AI. Uber, folks, is in hot water once again. This isn’t just another tech hiccup; it's a legal whirlwind brewing up courtesy of Edelson Lechtzin LLP, a...

Continue Reading
Portillo's Faces Class Action: Investor Losses at Stake

Updated Category News Views 37

Investor Tensions Rise as Portillo's Inc. Lawsuit Unfolds Investment ain't all sunshine and rainbows, and if you've been holding Portillo's Inc. (NASDAQ: PTLO) stocks between September 19, 2023, and May 4, 2026, you might find yourself caught in a storm front. We're talking shareholder class action lawsuit, folks, thanks to some allegedly misguided management moves. This...

Continue Reading
Layne's Chicken Fingers Expands with Brownsville Opening

Updated Category News Views 400

Fried Delights Rise in Brownsville Never thought I'd see the day when chicken fingers felt like the main character in an epic expansion saga, but here we are. Ricki Oberoi, a veteran in the fast-food game, is pushing onward with Layne's Chicken Fingers in Brownsville, Texas. I tell you, some folks are as keen on expanding their palates as they are their portfolios....

Continue Reading
KINGRVER Boosts RV Comfort with New Water Heater Lineup

Updated Category News Views 103

An Upgrade for the Open Road In the land of RV living, comfort is king—or in this case, KINGRVER. Dropping affordable upgrades for water heaters into the world of RVs, KINGRVER's CT6 lineup is like a warm hug on a chilly campsite morning. Whether you've pulled up to a wooded retreat or parked under the vast desert sky, having dependable hot water shouldn't be a gamble....

Continue Reading
Servier's Data on Tovorafenib Shows Promise in pLGG

Updated Category News Views 570

New Light on a Critical Challenge Talk about a fight in the dark. Pediatric low-grade glioma (pLGG) is a menace that families dread, an uphill battle with odds that feel relentless. Enter Servier and its four-year updated data on OJEMDA® (tovorafenib), a beacon of hope for kids battling these tricky brain tumors. Results, presented at the SNO meeting, are fresh off the...

Continue Reading
Championing Change: USTA Mid-Atlantic Gala's Impact

Updated Category News Views 142

A Night to Remember: USTA Mid-Atlantic's Gala Who would've thought tennis could wield such transformative power? This ain't your average sport gala. Last Saturday, a crowd of over 300 gathered at the Ritz-Carlton Tysons Corner for the USTA Mid-Atlantic Foundation's 2026 Tennis Creates Gala. Hosted by the formidable Malika Andrews, this event wasn't just a fancy...

Continue Reading
EZaccessMD Data Breach: Class Action Lawsuit Looms

Updated Category News Views 607

Data breaches are the bogeyman no one wants lurking in the shadows, and when it’s your personal info at stake, folks rightfully squirm. This recent fiasco at EZaccessMD is one of those unsettling incidents. The word on the street isn't pretty: sensitive medical data has slipped through the cracks, leaving Edelson Lechtzin LLP, a heavyweight in class action maneuvers, to...

Continue Reading
Ambrosia Biosciences Unveils Promising Nonclinical Metabolic Data

Updated Category News Views 136

Ambrosia's Latest Nonclinical Revelations Ambrosia Biosciences has just thrown out some major bait at ObesityWeek® 2026. The highlight? New nonclinical data profiles for two of their understudy small molecule programs—AMB-895 and AMB-131. It may sound niche, but in this sector, promising data spins heads. Their GLP-1 receptor agonist, AMB-895, and GIP receptor...

Continue Reading
HONGQI's EHS4 Launch in Europe: Bridging East and West

Updated Category News Views 265

Revving Up a New Chapter: HONGQI in Venice There's a new player in the European automotive scene, and it's rolling in with more style than a Venetian gondola. HONGQI, a name that's been turning gears in China since '58, is packing its suitcases full of Eastern elegance and landing straight in Venice with the all-electric EHS4. On November 16, the brand is set to unveil...

Continue Reading
Pan-Mass Challenge Gifts $80M to Dana-Farber for 2026

Updated Category News Views 16

A Momentous Gift in a Crunch Time for Cancer Research Biking and philanthropy might seem like an odd duo, but let me tell you, the Pan-Mass Challenge (PMC) is making that partnership look like peanut butter and jelly. This year, PMC rolled out a jaw-dropping $80 million gift to the Dana-Farber Cancer Institute. You heard right—eighty million smackeroos. Talk about going...

Continue Reading

Top 5 Most Recently Viewed Articles

Understanding the Latest Position Disclosure by Rathbones Group

Updated Category News Views 129

Understanding the Latest Position Disclosure by Rathbones Group In the competitive landscape of the financial market, the need for transparency has never been more critical, especially when it comes to securities that hold substantial stakes. Today, we delve into the recent disclosure made by Rathbones Group Plc regarding their position in Primary Health Properties Plc....

Continue Reading
Stride, Inc. Faces Major Concerns Following Platform Issues

Updated Category News Views 493

Stride, Inc. Experiences Significant Challenges Recent events have revealed substantial challenges for Stride, Inc. (NYSE: LRN), a company known for its online education platform. Following a significant operational issue stemming from a platform upgrade, the company’s stock has witnessed a dramatic decline, which has drawn the attention of investors and watchdogs...

Continue Reading
MoEngage Achieves Customers' Choice Recognition in 2025

Updated Category News Views 162

MoEngage Recognized as a Customers' Choice for Email Marketing MoEngage, a leader in customer engagement solutions, is thrilled to share its recognition as the only vendor to be named a Customers' Choice in the 2025 Gartner Peer Insights™ Voice of the Customer for Email Marketing report. Achieving an exceptional 97% "Willingness to Recommend" score, MoEngage stands out...

Continue Reading
Organon & Co. Faces Class Action Over Shareholder Losses

Updated Category News Views 212

Class Action Lawsuit Against Organon & Co. Investors may have an opportunity to lead a class action lawsuit against Organon & Co. This follows allegations that the company made misleading statements that adversely affected its stock performance. For those concerned about their investments, this could be a significant moment. Understanding the Class Definition The class...

Continue Reading
Exploring NVIDIA's Options Trading Insights and Trends

Updated Category News Views 86

NVIDIA's Strategic Options Trading In the world of financial investments, NVIDIA has captured significant attention from market giants through its recent options trading patterns. A thorough analysis of trading activities for NVIDIA (NASDAQ: NVDA) reveals not only an increase in volume but also a notable inclination among traders indicating bullish sentiments....

Continue Reading